<div id="readability-page-1"><p>Celsius (NASDAQ:CELH - Get Free Report) is expected to announce its  Q1 2026 results before the market opens on Thursday, May 7th. Analysts expect the company to announce earnings of $0.29 per share and revenue of $766.6350 million for the quarter. Investors can find conference call details on the company's upcoming Q1 2026 earning report page for the latest details on the call scheduled for Thursday, May 7, 2026 at 8:00 AM ET.</p><ul><li>MarketBeat Week in Review – 10/06 - 10/10</li></ul><p>Celsius (NASDAQ:CELH - Get Free Report) last issued its quarterly earnings results on Thursday, February 26th. The company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.19 by $0.07. Celsius had a net margin of 4.29% and a return on equity of 37.68%. The company had revenue of $721.63 million for the quarter, compared to the consensus estimate of $638.17 million. During the same quarter in the prior year, the company earned ($0.11) EPS. Celsius's quarterly revenue was up 117.2% on a year-over-year basis.  On average, analysts expect Celsius to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year. </p><h2>Celsius Price Performance</h2><p>Shares of NASDAQ:CELH opened at $33.73 on Monday. Celsius has a twelve month low of $32.01 and a twelve month high of $66.74. The company's 50 day moving average is $39.53 and its 200 day moving average is $45.74. The company has a current ratio of 1.68, a quick ratio of 1.37 and a debt-to-equity ratio of 0.57. The company has a market cap of $8.67 billion, a PE ratio of 134.92, a price-to-earnings-growth ratio of 1.34 and a beta of 0.95. </p><h2>Analyst Upgrades and Downgrades</h2><ul><li>Coca-Cola Stock Dips—Is CELH the Growth Your Portfolio Needs?</li></ul><p>Several research analysts recently weighed in on the company. Piper Sandler  reiterated an &#34;overweight&#34; rating and set a $65.00 price target (up from $61.00) on shares of Celsius in a research report on Thursday, January 29th. JPMorgan Chase &amp; Co. lifted their target price on shares of Celsius from $68.00 to $77.00 and gave the company an &#34;overweight&#34; rating in a report on Thursday, January 29th. Morgan Stanley  reaffirmed an &#34;overweight&#34; rating and set a $64.00 target price on shares of Celsius in a report on Tuesday, March 17th. UBS Group cut their target price on shares of Celsius from $72.00 to $62.00 and set a &#34;buy&#34; rating for the company in a report on Tuesday, April 7th. Finally, Needham &amp; Company LLC lifted their target price on shares of Celsius from $70.00 to $75.00 and gave the company a &#34;buy&#34; rating in a report on Friday, February 27th. Twenty equities research analysts have rated the stock with a Buy rating and three have issued  a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of &#34;Moderate Buy&#34; and a consensus price target of $65.72.</p><p><b>View Our Latest Report on Celsius</b></p><h2>Institutional Investors Weigh In On Celsius</h2><ul><li>MarketBeat Week in Review – 09/08 - 09/12</li></ul><p>Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Brevan Howard Capital Management LP acquired a new stake in  Celsius during the 2nd quarter worth $299,000.  NewEdge Advisors LLC boosted its stake in  Celsius by 11.6% during the 4th quarter. NewEdge Advisors LLC now owns 6,352 shares of the company's stock worth $291,000 after purchasing an additional 659 shares during the last quarter.  Boothbay Fund Management LLC acquired a new stake in  Celsius during the 2nd quarter worth $285,000.  Centaurus Financial Inc. acquired a new stake in  Celsius during the 3rd quarter worth $239,000.  Finally, FAS Wealth Partners Inc. boosted its stake in  Celsius by 10.2% during the 4th quarter. FAS Wealth Partners Inc. now owns 4,613 shares of the company's stock worth $211,000 after purchasing an additional 428 shares during the last quarter. Institutional investors and hedge funds own  60.95% of the company's stock. </p><h2>About Celsius</h2> (Get Free Report)<p>Celsius Holdings, Inc is an American beverage company known for its line of fitness and energy drinks formulated to support active lifestyles. The company's flagship product, the Celsius® brand, features beverages enhanced with ingredients such as green tea extract, guarana seed extract and essential vitamins, positioned as a functional alternative to traditional energy drinks. These products are designed to deliver a blend of ingredients that support metabolism and sustained energy without high sugar content or artificial preservatives.  </p><p>In addition to its core carbonated drink portfolio, Celsius has expanded its offerings to include powder mixes and non-carbonated ready-to-drink variants, catering to consumer preferences around taste, convenience and nutritional needs.</p><h2>Further Reading</h2><ul><li>Five stocks we like better than Celsius</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q0VMSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="325" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q0VMSA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Celsius Right Now?</h2><p>Before you consider Celsius, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celsius wasn't on the list.</p><p>While Celsius currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

CELH

CELT

FTXG

<p>Celsius (NASDAQ:CELH) is set to announce its Q1 2026 earnings on May 7, with expectations of $0.29 earnings per share and $766.635 million in revenue. The company previously reported $0.26 EPS for Q4 2025, exceeding estimates. Celsius shares opened at $33.73, with a market cap of $8.67 billion. Analysts maintain a positive outlook, with target prices ranging from $62 to $77. Institutional investors hold 60.95% of the stock, reflecting strong interest in the beverage company's growth potential.</p>

Market Beat

Celsius

iShares US Consumer Staples ETF

SPDR FD Consumer Staples

Tradr 2X Long CELH Daily ETF

First Trust NASDAQ Food & Beverage

VG Consumer Stap

Invesco Food & Beverage ETF

Coca Cola

Piper Sandler Cos

JPMorgan Chase

Morgan Stanley

UBS Group AG

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

Celsius (CELH) Expected to Announce Earnings on Thursday